10th Baltic Conference on Multiple Sclerosis and Autoimmune Disorders
Welcome from Conference Chair
Dear colleagues and friends,
On behalf of the Organizing Committee of the 10th Baltic Conference on Multiple Sclerosis and Autoimmune Disorders, I would like to welcome you to Tallinn on May 12th 2023. After years of severe crises and web-based meetings, we are finally able to meet in person.
Once again, we have developed a fascinating program. The conference will be covering topics on Multiple Sclerosis and autoimmune disorders of the nervous system. Our conference program presents keynote speakers Professor Airas from Finland, Professor Langdon from the UK, Professor Sellner from Austria and of course, our Baltic colleagues. The very best speakers from all Baltic states will be presenting a curated selection of exciting and practice-changing topics.
Consider this a very warm welcome to join us in Tallinn this spring,
Katrin Gross-Paju MD, PhD
Organizing Committee
Professor Rasa Kizlaitiene
Professor Andrejs Millers
Assoc. Professor Katrin Gross-Paju
Contact information
Dr. Sandra Ütt
Keynote speakers
Laura Airas
Professor, Clinical Neurosciences InFLAMES Flagship, Professor of Neuroimmunology, University of Turku, Finland
Dawn Langdon
Professor of Neuropsychology, Royal Holloway, University of London, UK
Johann Sellner
Professor, Chair, Department of Neurology and Multiple Sclerosis Center, Landesklinikum Mistelbach-Gänserndorf, Austria
Scientific Program
| 9.00 | Welcome and introduction Katrin Gross-Paju |
| 9.05–9.45 | Janssen Satellite Symposium New developments in Multiple Sclerosis Xavier Montalban (Barcelona, Spain) |
| 9.50–10.10 | Novartis Satellite Symposium High-efficacy immunotherapy in the management of multiple sclerosis: lessons learnt from observational data Tomas Kalincik (Melbourne, Australia) |
SESSION I Multiple Sclerosis IChairs: Rasa Kizlaitiene, Katrin Gross-Paju |
|
| 10.30–11.15 | Smoldering leasions in Multiple sclerosis Laura Airas (Turku, Finland) |
| 11.15–11.40 | Individual treatment decisions in multiple sclerosis Katrin Gross-Paju (Tallinn, Estonia) |
| 11.40–12.05 | Progressive Multiple Sclerosis: when to diagnose and start treatment? Rasa Kizlaitienė, Ieva Sereikė, Mykolas Jocys, Gintaras Kaubrys (Vilnius, Lithuania) |
| 12.05–12.20 | High dose chemotherapy cases and literature overview Sandra Ütt (Tallinn, Estonia) |
| 12.20–12.40 | Association analysis of intergenic polymorphism of the HLA locus as a possible molecular marker of Multiple sclerosis in a case/control study in the Latvian population Jolanta Kalnina, Ilva Trapiņa, Nikolajs Sjakste, Natalia Paramonova (Riga, Latvia) |
| 12.40–13.45 | Lunch |
SESSION II Multiple sclerosis IIChairs: Andrejs Millers, Laura Airas |
|
| 13.45–14.30 | Cognitive changes in multiple sclerosis Dawn Langdon (London, UK) |
| 14.30–14.50 | Sleep disorders and fatigue in multiple sclerosis: association and interaction. Gabrielė Pupelytė, Indrė Eitmonaitė, Evelina Pajėdienė, Dalia Mickevičienė (Kaunas, Lithuania) |
| 14.50–15.10 | Identifying factors associated with the progression from Clinically Isolated Syndrome to Multiple Sclerosis Miglė Malciūtė, Radvilė Stankevičiūtė, Ieva Čelpalčenko, Renata Balnytė (Kaunas, Lithuania) |
| 15.10–15.30 | Relation between brain MRI volumetry results and changes in EDSS among patients with multiple sclerosis during a 5-year follow-up Sintija Strautmane, Arturs Balodis, Agnete Teivāne, Dagnija Grabovska, Edgars Fišermans, Dāniels Urbanovičs, Edgars Naudiņš, Jānis Mednieks, Alīna Flintere-Flinte, Zanda Priede, Andrejs Millers, Maksims Zolovs (Riga, Latvia) |
| 15.30–16.00 | Coffee break |
SESSION III Autoimmune diseasesChairs: Pille Taba, Sulev Haldre |
|
| 16.00–16.45 | COVID-19 and autoimmunity: emerging neurological manifestations Johann Sellner (Mistelbach-Gänserndorf, Austria) |
| 16.45–17.00 | Evolving concept of autoimmune encephalitis and paraneoplastic neurological syndromes Mantas Vaišvilas, Nataša Giedraitienė (Vilnius, Lithuania) |
| 17.00–17.15 | Nodal/paranodal antibody positive syndromes in Estonia Triin Helin Unt (Tallinn, Estonia) |
| 17.15–17.30 | NMOSD – new therapies offer hope (Case report) Alīna Flintere-Flinte, Solveiga Zālīte (Riga, Latvia) |
| 17.30–18.00 | Coffee break |
SESSION IV casesChairs: Laura Airas, Johann Sellner |
|
| 18.00-18.15 | Case report Inger Tark (Tallinn, Estonia) |
| 18.15–18.30 | Patient with MOG antibody disease and thrombophilia Elīna Polunosika, Daina Pastare, Guntis Karelis (Riga, Latvia) |
| 18.30–18.45 | Autoimmune cerebellitis as an adverse event of immune checkpoint inhibition Domantas Valančius, Irena Zagorskienė, Aušra Klimašauskienė (Vilnius, Lithuania) |
| 18.45–19.00 | Case report Alo-Rainer Lehiste (Tartu, Estonia) |
| 19.00–19.15 | Idiopathic hypertrophic pachymeningitis Laura Gribuste, Ziedīte Želve, Daina Pastare, Guntis Karelis (Riga, Latvia) |
| 20.00 | Dinner at restaurant Olde Hansa |
Sponsors
Gold sponsors
Silver sponsors
Bronze sponsors
Tallinn
Tallinn is the capital city of Estonia and a perfect holiday destination if you want to combine the comforts of modern world, versatile nightlife and luxurious adventures with rich cultural scene in the local historical setting. More information:
